M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Surmodics to be acquired by GTCR for USD627m
Surmodics Inc (Nasdaq: SRDX), a provider of medical device and diagnostic technologies, revealed on Wednesday that it has entered a definitive agreement to be acquired by private equity firm GTCR for USD43.00 per share in cash, representing an equity value of approximately USD627m. The...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search